• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善糖尿病视网膜病变的危险因素筛查。

Improving the screening of risk factors in diabetic retinopathy.

机构信息

Consultant Ophthalmologist, Department of Ophthalmologist, Gloucestershire Hospitals NHS Foundation Trust Cheltenham, UK.

National Clinical Lead, NHS Diabetic Eye Screening Programme (Ophthalmology), Public Health Commissioning and Operations, England.

出版信息

Expert Rev Endocrinol Metab. 2022 May;17(3):235-243. doi: 10.1080/17446651.2022.2078305.

DOI:10.1080/17446651.2022.2078305
PMID:35730170
Abstract

INTRODUCTION

In 2002, Diabetic Retinopathy was reported as the leading cause of blindness in the working age group. The introduction of systematic screening programs in the UK has reduced visual loss and blindness due to diabetic retinopathy, but it does still occur with catastrophic consequences for the individual.

AREAS COVERED

The author conducted an ongoing search for articles relating to diabetic retinopathy since 2000 utilizing Zetoc Alert with keywords and contents page lists from relevant journals. This review covers the risk factors for loss of vision due to diabetic retinopathy and discusses ways in which the awareness of these risk factors can be used to further reduce visual loss. Some risk factors such as glycemic and B/P control are well known from landmark trials. This review has included these factors but concentrated more on the evidence behind those risk factors that are not so clearly defined or so well known.

EXPERT OPINION

The major risk factors are well known, but one continues to find that people with diabetes lose vision in situations in which a better awareness of the risks by both the individual with diabetes and the health workers involved may have prevented the visual loss.

摘要

简介

2002 年,糖尿病视网膜病变被报道为导致工作年龄段人群失明的主要原因。英国引入系统的筛查计划已经减少了糖尿病视网膜病变导致的视力丧失和失明,但它仍然会给个人带来灾难性的后果。

涵盖领域

作者自 2000 年以来,利用 Zetoc Alert 进行了一项关于糖尿病视网膜病变的持续搜索,使用关键字和相关期刊的目录页列表。本综述涵盖了由于糖尿病视网膜病变导致视力丧失的风险因素,并讨论了如何利用这些风险因素的认识来进一步减少视力丧失。一些风险因素,如血糖和血压控制,已经从标志性试验中得到证实。本综述包括了这些因素,但更侧重于那些风险因素的证据,这些因素并不那么明确或广为人知。

专家意见

主要风险因素是众所周知的,但人们仍然发现,糖尿病患者在某些情况下会失去视力,如果糖尿病患者和相关卫生工作者对这些风险有更好的认识,可能已经预防了视力丧失。

相似文献

1
Improving the screening of risk factors in diabetic retinopathy.改善糖尿病视网膜病变的危险因素筛查。
Expert Rev Endocrinol Metab. 2022 May;17(3):235-243. doi: 10.1080/17446651.2022.2078305.
2
Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.糖尿病性视网膜病变。失明的筛查与预防。博士论文。
Acta Ophthalmol Scand Suppl. 1997(223):1-76.
3
Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes.预防糖尿病性视网膜病变导致的失明。控制血糖和血压,并监测眼睛。
Prescrire Int. 2010 Feb;19(105):35-8.
4
Diabetic retinopathy screening: global and local perspective.糖尿病视网膜病变筛查:全球及本地视角
Hong Kong Med J. 2016 Oct;22(5):486-95. doi: 10.12809/hkmj164844. Epub 2016 Aug 26.
5
Systemic considerations in the management of diabetic retinopathy.糖尿病视网膜病变管理中的全身因素考量
Am J Ophthalmol. 2001 Nov;132(5):760-76. doi: 10.1016/s0002-9394(01)01124-2.
6
Update on Screening for Sight-Threatening Diabetic Retinopathy.筛查威胁视力的糖尿病视网膜病变进展。
Ophthalmic Res. 2019;62(4):218-224. doi: 10.1159/000499539. Epub 2019 May 27.
7
Lowering the risk of visual impairment and blindness.降低视力损害和失明的风险。
Diabet Med. 1998;15 Suppl 4:S47-50. doi: 10.1002/(sici)1096-9136(1998120)15:4+<s47::aid-dia739>3.3.co;2-j.
8
Management of diabetic retinopathy.糖尿病视网膜病变的管理
Am Fam Physician. 1995 Mar;51(4):785-96.
9
Etiology and natural history of diabetic retinopathy: an overview.糖尿病视网膜病变的病因及自然病史:综述
Am J Health Syst Pharm. 2007 Sep 1;64(17 Suppl 12):S3-7. doi: 10.2146/ajhp070330.
10
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.英国国民保健制度糖尿病眼病筛查计划对减少与糖尿病相关的失明的贡献、欧洲内部的比较以及未来的挑战。
Acta Diabetol. 2021 Apr;58(4):521-530. doi: 10.1007/s00592-021-01687-w. Epub 2021 Apr 8.

引用本文的文献

1
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk.一种基于评分的简单策略,以提高英国两年一次的糖尿病眼部筛查方案在被视为低风险人群中的公平性。
Diabetologia. 2025 Jun;68(6):1157-1168. doi: 10.1007/s00125-025-06379-6. Epub 2025 Mar 12.
2
Evaluation of the effect of full-process blood glucose management on T2DM cataract patients based on visual electrophysiology and OCTA.基于视觉电生理学和 OCTA 评估全程血糖管理对 T2DM 白内障患者的影响。
Sci Rep. 2024 Nov 13;14(1):27862. doi: 10.1038/s41598-024-76510-x.
3
Plasma matrix metalloproteinases and tissue inhibitors of metalloproteinases explored in relation to the severity and progression of diabetic retinopathy in patients with type 1 diabetes: baseline and prospective analyses.
探讨了 1 型糖尿病患者血浆基质金属蛋白酶和金属蛋白酶组织抑制剂与糖尿病视网膜病变严重程度和进展的关系:基线和前瞻性分析。
BMJ Open Ophthalmol. 2024 Jul 11;9(1):e001583. doi: 10.1136/bmjophth-2023-001583.
4
Effect of High-Sucrose Diet on the Occurrence and Progression of Diabetic Retinopathy and Dietary Modification Strategies.高糖饮食对糖尿病视网膜病变的发生和进展的影响及饮食调整策略。
Nutrients. 2024 May 5;16(9):1393. doi: 10.3390/nu16091393.
5
Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study.在新加坡延长糖尿病视网膜病变筛查间隔时间:一项队列研究的方法学和初步发现。
BMC Public Health. 2024 Mar 13;24(1):786. doi: 10.1186/s12889-024-18287-2.
6
Soluble CD163 and glycated haemoglobin were independently associated with the progression of diabetic retinopathy in adult patients with type 1 diabetes.可溶性 CD163 和糖化血红蛋白与 1 型糖尿病成年患者糖尿病视网膜病变的进展独立相关。
BMJ Open Ophthalmol. 2023 Jul;8(1). doi: 10.1136/bmjophth-2023-001314.
7
Semaglutide-eye-catching results.司美格鲁肽——引人注目的结果。
World J Diabetes. 2023 Apr 15;14(4):424-434. doi: 10.4239/wjd.v14.i4.424.
8
Can the level of HbAC predict diabetic retinopathy among type II diabetic patients?HbAC 水平能否预测 2 型糖尿病患者的糖尿病视网膜病变?
BMC Ophthalmol. 2022 Oct 31;22(1):415. doi: 10.1186/s12886-022-02608-3.
9
Differences in Multifocal Electroretinogram Study in Two Populations of Type 1 and Type 2 Diabetes Mellitus Patients without Diabetic Retinopathy.1型和2型糖尿病无糖尿病视网膜病变患者两组人群的多焦视网膜电图研究差异
J Clin Med. 2022 Sep 30;11(19):5824. doi: 10.3390/jcm11195824.